• @[email protected]
    link
    fedilink
    281 year ago

    The drugs selected to undergo negotiations are:

    • Eliquis, a blood thinner
    • Xarelto, a blood thinner
    • Januvia, a diabetes drug
    • Jardiance, a diabetes drug
    • Enbrel, a rheumatoid arthritis drug
    • Imbruvica, a drug for blood cancers
    • Farxiga, a drug for diabetes, heart failure and chronic kidney disease
    • Entresto, a heart failure drug
    • Stelara, a drug for psoriasis and Crohn’s disease
    • Fiasp and NovoLog, for diabetes

    (via NBC)

    • @Fredselfish
      link
      81 year ago

      So just for fucking boomers again fuck us young people.

        • @lando55
          link
          English
          21 year ago

          I couldn’t say for certain, but perhaps fewer to treat congestive heart disease and other coronary ailments

          • @[email protected]
            link
            fedilink
            11 year ago

            Other people getting less stuff doesn’t help you though. I wish more drugs were included, but I don’t wish there were fewer drugs covered. I suspect that almost any disease a younger person has, an older person is even more likely to have it.

      • AnonTwo
        link
        fedilink
        71 year ago

        Isn’t Medicare mostly boomers in the first place, or am I wrong?

        • WagesOf
          link
          fedilink
          61 year ago

          Yes. I think they looked at the top prescription drug costs, including volume, and took aim at the ones where discounts would save the most.

      • @lemmyman
        link
        41 year ago

        Medicare is for old people, what did you expect?

      • GodlessCommie
        link
        21 year ago

        Yep, the same ‘boot strap’ boomers. Even today, being given everything on a fucking silver platter so they can claim younger generations have it so easy and are lazy compared to struggles they grew up with like affordable housing, 1 income households, cheap or free higher education, strong labor unions, etc.